{
  "release_id": "a25293eeae6350fb",
  "id": "cardio:amiodarone",
  "owner": "cardio",
  "kind": "drug",
  "slug": "amiodarone",
  "name": "Amiodarone",
  "aliases": [
    "Pacerone",
    "Nexterone",
    "Cordarone"
  ],
  "atlases": [
    "cardio"
  ],
  "summary_plain": "Amiodarone is an antiarrhythmic medicine. Its US labels describe two forms: tablets (Pacerone is a US brand) and an injection (Nexterone). The tablet label lists documented, life-threatening recurrent ventricular fibrillation and life-threatening recurrent hemodynamically unstable ventricular tachycardia in adults who have not responded to other available antiarrhythmics or cannot tolerate them. The injection label lists treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy. The tablet label carries a boxed warning: the medicine is intended only for the indicated life-threatening arrhythmias because its use is accompanied by substantial toxicity, and it can cause lung toxicity, liver toxicity that can be fatal, and worse arrhythmias. Cordarone, the brand approved in 1985 under NDA018972, is listed as discontinued.",
  "summary_technical": "RxNorm ingredient 703 (amiodarone); UNII 976728SY6Z is the UNII of the salt, amiodarone hydrochloride, that the labels give, so it is a broad match; US drug-label class Antiarrhythmic (established pharmacologic class, RxClass). Labels read: Pacerone tablets (Upsher-Smith, abbreviated application ANDA075135, effective 2025-07-14) and Nexterone injection (Baxter, NDA022325, effective 2024-04-16). Other openFDA amiodarone labels, from generic and repackager sponsors, were listed and not used. Cordarone tablets (Wyeth, NDA018972) are listed in Drugs@FDA with marketing status Discontinued; the original approval is dated 1985-12-24, classified as a Type 1 new molecular entity with priority review. The tablet indication sentence says \"unstable tachycardia\" without the word ventricular; the Highlights line of the same label names ventricular tachycardia. Neither label lists atrial fibrillation, atrial flutter or supraventricular tachycardia. This page records label statements and the class only: no trial result and no dose is recorded.",
  "editorial_state": "draft",
  "last_substantive_edit": "2026-10-30",
  "last_evidence_check": "2026-10-30",
  "next_review_due": null,
  "identifiers": [
    {
      "scheme": "rxnorm",
      "value": "703",
      "normalized_value": "703",
      "match": "exact",
      "version": null,
      "label": null,
      "from_source": false
    },
    {
      "scheme": "unii",
      "value": "976728SY6Z",
      "normalized_value": "976728SY6Z",
      "match": "broad",
      "version": null,
      "label": "Amiodarone hydrochloride",
      "from_source": false
    }
  ],
  "navigation": {
    "cardio": {
      "system": [
        "heart"
      ],
      "condition-area": [
        "arrhythmias"
      ]
    }
  },
  "payload": {
    "level": "substance",
    "mechanism": "The label says amiodarone is considered a class III antiarrhythmic drug but has electrophysiologic characteristics of all four Vaughan Williams classes."
  },
  "content_digest": "51943232d4885d18223dda4bfc0b5b77b6908c70cb241d98c96621e942e9e28f",
  "review": {
    "content_digest": "51943232d4885d18223dda4bfc0b5b77b6908c70cb241d98c96621e942e9e28f",
    "current": [],
    "conflicting": [],
    "stale": [],
    "inactive": []
  },
  "claims": [
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-nda018972-cordarone-record",
      "owner": "cardio",
      "subject_entity_id": "cardio:amiodarone",
      "category": "regulatory",
      "statement": "The openFDA Drugs@FDA record for New Drug Application NDA018972 names WYETH PHARMS as sponsor and lists one product, CORDARONE tablets (amiodarone hydrochloride), with marketing status Discontinued. It lists the original approval as submission ORIG-1, with status date 24 December 1985, classified as Type 1 - New Molecular Entity, with priority review.",
      "context": {
        "id": "cardio:ctx-fda-nda018972-cordarone-us",
        "label": "United States approval record NDA018972 for Cordarone (amiodarone hydrochloride tablets)",
        "recipient": "unknown",
        "population": "Not stated in the fetched Drugs@FDA record. It names a product and a sponsor and gives no intended population or indication.",
        "care_setting": "Not stated in the FDA record",
        "geography": "United States (decision by the US Food and Drug Administration)",
        "life_stage_note": "Not stated in the FDA record",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (regulatory decision)",
        "eligibility": {
          "inclusion": [],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records the original approval and the status the record gives, as of the fetch date. The record carries no indication text for the original approval, so it does not say what the medicine was approved to treat in 1985. It lists many later supplements. A discontinued status says the product is not marketed under this application; it is not a finding about safety or effectiveness. An approval is not a finding about how well the medicine works. openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-10-30",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].application_number",
          "applicability_note": "The application number of this record.",
          "snapshot": {
            "id": "cardio:openfda-drugsfda-nda018972-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:06Z",
            "content_hash": "92c954cf9ed6c46ab0fafd51aff46801c841dfa1f05982f98d47d36ffe7d713d",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-drugsfda-nda018972",
            "source_type": "regulator",
            "title": "openFDA Drugs@FDA record for NDA018972 (CORDARONE, amiodarone hydrochloride tablets)",
            "canonical_url": "https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA018972%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "openFDA Drugs@FDA application record returned on 2026-10-30. It lists the original approval as submission ORIG-1, with an approval status date of 19851224, and one product, CORDARONE tablets, with marketing status Discontinued.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). The raw record is committed at research/snapshots/cs-openfda-drugsfda-NDA018972.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].sponsor_name",
          "applicability_note": "The application sponsor, as the record writes the name.",
          "snapshot": {
            "id": "cardio:openfda-drugsfda-nda018972-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:06Z",
            "content_hash": "92c954cf9ed6c46ab0fafd51aff46801c841dfa1f05982f98d47d36ffe7d713d",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-drugsfda-nda018972",
            "source_type": "regulator",
            "title": "openFDA Drugs@FDA record for NDA018972 (CORDARONE, amiodarone hydrochloride tablets)",
            "canonical_url": "https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA018972%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "openFDA Drugs@FDA application record returned on 2026-10-30. It lists the original approval as submission ORIG-1, with an approval status date of 19851224, and one product, CORDARONE tablets, with marketing status Discontinued.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). The raw record is committed at research/snapshots/cs-openfda-drugsfda-NDA018972.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].products[0].brand_name",
          "applicability_note": "The product brand name.",
          "snapshot": {
            "id": "cardio:openfda-drugsfda-nda018972-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:06Z",
            "content_hash": "92c954cf9ed6c46ab0fafd51aff46801c841dfa1f05982f98d47d36ffe7d713d",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-drugsfda-nda018972",
            "source_type": "regulator",
            "title": "openFDA Drugs@FDA record for NDA018972 (CORDARONE, amiodarone hydrochloride tablets)",
            "canonical_url": "https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA018972%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "openFDA Drugs@FDA application record returned on 2026-10-30. It lists the original approval as submission ORIG-1, with an approval status date of 19851224, and one product, CORDARONE tablets, with marketing status Discontinued.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). The raw record is committed at research/snapshots/cs-openfda-drugsfda-NDA018972.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].products[0].marketing_status",
          "applicability_note": "The product marketing status.",
          "snapshot": {
            "id": "cardio:openfda-drugsfda-nda018972-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:06Z",
            "content_hash": "92c954cf9ed6c46ab0fafd51aff46801c841dfa1f05982f98d47d36ffe7d713d",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-drugsfda-nda018972",
            "source_type": "regulator",
            "title": "openFDA Drugs@FDA record for NDA018972 (CORDARONE, amiodarone hydrochloride tablets)",
            "canonical_url": "https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA018972%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "openFDA Drugs@FDA application record returned on 2026-10-30. It lists the original approval as submission ORIG-1, with an approval status date of 19851224, and one product, CORDARONE tablets, with marketing status Discontinued.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). The raw record is committed at research/snapshots/cs-openfda-drugsfda-NDA018972.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].submissions[27].submission_type",
          "applicability_note": "The original submission.",
          "snapshot": {
            "id": "cardio:openfda-drugsfda-nda018972-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:06Z",
            "content_hash": "92c954cf9ed6c46ab0fafd51aff46801c841dfa1f05982f98d47d36ffe7d713d",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-drugsfda-nda018972",
            "source_type": "regulator",
            "title": "openFDA Drugs@FDA record for NDA018972 (CORDARONE, amiodarone hydrochloride tablets)",
            "canonical_url": "https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA018972%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "openFDA Drugs@FDA application record returned on 2026-10-30. It lists the original approval as submission ORIG-1, with an approval status date of 19851224, and one product, CORDARONE tablets, with marketing status Discontinued.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). The raw record is committed at research/snapshots/cs-openfda-drugsfda-NDA018972.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].submissions[27].submission_status_date",
          "applicability_note": "The original approval status date, in compact form.",
          "snapshot": {
            "id": "cardio:openfda-drugsfda-nda018972-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:06Z",
            "content_hash": "92c954cf9ed6c46ab0fafd51aff46801c841dfa1f05982f98d47d36ffe7d713d",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-drugsfda-nda018972",
            "source_type": "regulator",
            "title": "openFDA Drugs@FDA record for NDA018972 (CORDARONE, amiodarone hydrochloride tablets)",
            "canonical_url": "https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA018972%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "openFDA Drugs@FDA application record returned on 2026-10-30. It lists the original approval as submission ORIG-1, with an approval status date of 19851224, and one product, CORDARONE tablets, with marketing status Discontinued.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). The raw record is committed at research/snapshots/cs-openfda-drugsfda-NDA018972.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].submissions[27].submission_class_code_description",
          "applicability_note": "The submission classification of the original approval.",
          "snapshot": {
            "id": "cardio:openfda-drugsfda-nda018972-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:06Z",
            "content_hash": "92c954cf9ed6c46ab0fafd51aff46801c841dfa1f05982f98d47d36ffe7d713d",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-drugsfda-nda018972",
            "source_type": "regulator",
            "title": "openFDA Drugs@FDA record for NDA018972 (CORDARONE, amiodarone hydrochloride tablets)",
            "canonical_url": "https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA018972%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "openFDA Drugs@FDA application record returned on 2026-10-30. It lists the original approval as submission ORIG-1, with an approval status date of 19851224, and one product, CORDARONE tablets, with marketing status Discontinued.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). The raw record is committed at research/snapshots/cs-openfda-drugsfda-NDA018972.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].submissions[27].review_priority",
          "applicability_note": "The review priority of the original approval.",
          "snapshot": {
            "id": "cardio:openfda-drugsfda-nda018972-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:06Z",
            "content_hash": "92c954cf9ed6c46ab0fafd51aff46801c841dfa1f05982f98d47d36ffe7d713d",
            "source_effective_date": null,
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-drugsfda-nda018972",
            "source_type": "regulator",
            "title": "openFDA Drugs@FDA record for NDA018972 (CORDARONE, amiodarone hydrochloride tablets)",
            "canonical_url": "https://api.fda.gov/drug/drugsfda.json?search=application_number:%22NDA018972%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "openFDA Drugs@FDA application record returned on 2026-10-30. It lists the original approval as submission ORIG-1, with an approval status date of 19851224, and one product, CORDARONE tablets, with marketing status Discontinued.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). The raw record is committed at research/snapshots/cs-openfda-drugsfda-NDA018972.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "4d469bccf8a404858948c1a91cf6098d32fea13737f5b6e3d973b24897c7c197",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-nda018972-cordarone-record.json"
    },
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-nexterone-label-indications",
      "owner": "cardio",
      "subject_entity_id": "cardio:amiodarone",
      "category": "descriptive",
      "statement": "The US label of Nexterone (amiodarone injection, Baxter), in the version dated 16 April 2024 in openFDA, lists the injection for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy.",
      "context": {
        "id": "cardio:ctx-fda-nexterone-label-us",
        "label": "Patients refractory to other therapy for whom the US label of amiodarone injection (Nexterone) lists an indication: frequently recurring ventricular fibrillation or hemodynamically unstable ventricular tachycardia",
        "recipient": "unknown",
        "population": "Patients described in the indications section of the label. The label sentence gives no age range.",
        "care_setting": "Prescription medicine given as an injection, as described in the US label",
        "geography": "United States (label of the US Food and Drug Administration)",
        "life_stage_note": "Not stated in the label passage read",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Patients with frequently recurring ventricular fibrillation who are refractory to other therapy",
            "Patients with hemodynamically unstable ventricular tachycardia who are refractory to other therapy"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records what the label says it is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. Only the first indication sentence was read; the record has no boxed warning field, and warnings, doses and interactions were not read. Labels change, and openFDA lists other injection labels with other text. openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-10-30",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1, sentence 1, fragment 1 of 2",
          "applicability_note": "Indication, first part.",
          "snapshot": {
            "id": "cardio:openfda-label-nexterone-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:55Z",
            "content_hash": "bb5fd04fceab84988417e394dd950279d8e65de001585c3bffe5b92e1c663231",
            "source_effective_date": "2024-04-16",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-nexterone",
            "source_type": "regulator",
            "title": "openFDA drug label record for Nexterone (amiodarone injection), Baxter label: indications",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%22e9108958-b8d7-4fba-87c3-9a32990de551%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id e9108958-b8d7-4fba-87c3-9a32990de551 (manufacturer Baxter Healthcare Corporation; NDA022325), returned on 2026-10-30. The label text is dated 2024-04-16 (effective_time). A repackager label of Nexterone (HealthFirst, 2024-02-19) and the labels of other amiodarone injections were listed and not used. The record carries no boxed warning field.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/cs-openfda-label-nexterone-baxter-c.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1, sentence 1, fragment 2 of 2",
          "applicability_note": "Indication, second part: ventricular tachycardia and prior therapy.",
          "snapshot": {
            "id": "cardio:openfda-label-nexterone-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:55Z",
            "content_hash": "bb5fd04fceab84988417e394dd950279d8e65de001585c3bffe5b92e1c663231",
            "source_effective_date": "2024-04-16",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-nexterone",
            "source_type": "regulator",
            "title": "openFDA drug label record for Nexterone (amiodarone injection), Baxter label: indications",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%22e9108958-b8d7-4fba-87c3-9a32990de551%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id e9108958-b8d7-4fba-87c3-9a32990de551 (manufacturer Baxter Healthcare Corporation; NDA022325), returned on 2026-10-30. The label text is dated 2024-04-16 (effective_time). A repackager label of Nexterone (HealthFirst, 2024-02-19) and the labels of other amiodarone injections were listed and not used. The record carries no boxed warning field.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/cs-openfda-label-nexterone-baxter-c.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20240416.",
          "snapshot": {
            "id": "cardio:openfda-label-nexterone-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:55Z",
            "content_hash": "bb5fd04fceab84988417e394dd950279d8e65de001585c3bffe5b92e1c663231",
            "source_effective_date": "2024-04-16",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-nexterone",
            "source_type": "regulator",
            "title": "openFDA drug label record for Nexterone (amiodarone injection), Baxter label: indications",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%22e9108958-b8d7-4fba-87c3-9a32990de551%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id e9108958-b8d7-4fba-87c3-9a32990de551 (manufacturer Baxter Healthcare Corporation; NDA022325), returned on 2026-10-30. The label text is dated 2024-04-16 (effective_time). A repackager label of Nexterone (HealthFirst, 2024-02-19) and the labels of other amiodarone injections were listed and not used. The record carries no boxed warning field.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/cs-openfda-label-nexterone-baxter-c.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "0a93e1b3a61140c1dd1c22d1838594106d8b4f5b94cdf5fd0222b00987ba7187",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-nexterone-label-indications.json"
    },
    {
      "release_id": "a25293eeae6350fb",
      "id": "cardio:claim-fda-pacerone-label-indications",
      "owner": "cardio",
      "subject_entity_id": "cardio:amiodarone",
      "category": "descriptive",
      "statement": "The US label of Pacerone (amiodarone hydrochloride tablets, Upsher-Smith), in the version dated 14 July 2025 in openFDA, lists the tablets for documented, life-threatening recurrent ventricular fibrillation and life-threatening recurrent hemodynamically unstable tachycardia in adults who have not responded to adequate doses of other available antiarrhythmics or when alternative agents cannot be tolerated. The Highlights lines of the label name recurrent ventricular fibrillation and recurrent hemodynamically unstable ventricular tachycardia. The label carries a boxed warning titled pulmonary, hepatic and cardiac toxicity. It says the medicine is intended for use only in patients with the indicated life-threatening arrhythmias because its use is accompanied by substantial toxicity, that it can cause pulmonary toxicity and liver toxicity that can be fatal, and that it can exacerbate arrhythmias.",
      "context": {
        "id": "cardio:ctx-fda-pacerone-label-us",
        "label": "Adults for whom the US label of amiodarone tablets (Pacerone) lists an indication: life-threatening recurrent ventricular fibrillation or recurrent hemodynamically unstable ventricular tachycardia",
        "recipient": "adult",
        "population": "Adults described in the indications section of the label; the indication sentence is written for adults.",
        "care_setting": "Prescription medicine in tablet form, as described in the US label; the boxed warning says to initiate it in a clinical setting where continuous electrocardiograms and cardiac resuscitation are available",
        "geography": "United States (label of the US Food and Drug Administration)",
        "life_stage_note": "Adults, as the label states",
        "life_stage_terms": null,
        "gestational_age_min_days": null,
        "gestational_age_max_days": null,
        "gestational_age_basis": null,
        "postnatal_age_min_days": null,
        "postnatal_age_max_days": null,
        "gestational_age_status": null,
        "postnatal_age_status": null,
        "followup_description": "Not applicable (label statement)",
        "eligibility": {
          "inclusion": [
            "Adults with documented, life-threatening recurrent ventricular fibrillation",
            "Adults with life-threatening recurrent hemodynamically unstable ventricular tachycardia",
            "Adults who have not responded to adequate doses of other available antiarrhythmics or who cannot tolerate alternative agents"
          ],
          "exclusion": []
        }
      },
      "evidence_stage": "not_applicable",
      "certainty": "not_assessed",
      "certainty_method": null,
      "limitations": "This claim records what the label says it is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. Only the indications, the main lines of the boxed warning and the first sentence on mechanism were read; contraindications, doses, interactions and other warnings were not recorded. The label sentence says \"unstable tachycardia\" without the word ventricular; the ventricular wording is in the Highlights line. Labels change: openFDA also lists repackager copies and other amiodarone labels with other text. openFDA's own disclaimer says not to rely on it for decisions about medical care.",
      "editorial_state": "draft",
      "checked_at": "2026-10-30",
      "next_review_due": null,
      "valid_from": null,
      "valid_to": null,
      "citations": [
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1, sentence 1, fragment 1 of 2",
          "applicability_note": "Indication, first part.",
          "snapshot": {
            "id": "cardio:openfda-label-pacerone-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:30Z",
            "content_hash": "634bb6709ac6c7617c0112368b9bc30cf00ea37e42a72ee3e2302b2ee7725e3b",
            "source_effective_date": "2025-07-14",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-pacerone",
            "source_type": "regulator",
            "title": "openFDA drug label record for Pacerone (amiodarone hydrochloride tablets), Upsher-Smith label: indications, boxed warning and mechanism",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%224c4ec9b0-13a5-49a8-b57b-b3f64e4316a7%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 4c4ec9b0-13a5-49a8-b57b-b3f64e4316a7 (manufacturer Upsher-Smith Laboratories, LLC; abbreviated application ANDA075135), returned on 2026-10-30. The label text is dated 2025-07-14 (effective_time). Two repackager labels of Pacerone (Aphena, 2024-02-02; Bryant Ranch Prepack, 2025-11-05) and the labels of other amiodarone tablets and injections were listed and not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/cs-openfda-label-pacerone-us-b.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1, sentence 1, fragment 2 of 2",
          "applicability_note": "Indication, second part: adults and the condition on prior therapy.",
          "snapshot": {
            "id": "cardio:openfda-label-pacerone-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:30Z",
            "content_hash": "634bb6709ac6c7617c0112368b9bc30cf00ea37e42a72ee3e2302b2ee7725e3b",
            "source_effective_date": "2025-07-14",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-pacerone",
            "source_type": "regulator",
            "title": "openFDA drug label record for Pacerone (amiodarone hydrochloride tablets), Upsher-Smith label: indications, boxed warning and mechanism",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%224c4ec9b0-13a5-49a8-b57b-b3f64e4316a7%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 4c4ec9b0-13a5-49a8-b57b-b3f64e4316a7 (manufacturer Upsher-Smith Laboratories, LLC; abbreviated application ANDA075135), returned on 2026-10-30. The label text is dated 2025-07-14 (effective_time). Two repackager labels of Pacerone (Aphena, 2024-02-02; Bryant Ranch Prepack, 2025-11-05) and the labels of other amiodarone tablets and injections were listed and not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/cs-openfda-label-pacerone-us-b.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1, highlights, item 1",
          "applicability_note": "Highlights line: ventricular fibrillation.",
          "snapshot": {
            "id": "cardio:openfda-label-pacerone-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:30Z",
            "content_hash": "634bb6709ac6c7617c0112368b9bc30cf00ea37e42a72ee3e2302b2ee7725e3b",
            "source_effective_date": "2025-07-14",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-pacerone",
            "source_type": "regulator",
            "title": "openFDA drug label record for Pacerone (amiodarone hydrochloride tablets), Upsher-Smith label: indications, boxed warning and mechanism",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%224c4ec9b0-13a5-49a8-b57b-b3f64e4316a7%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 4c4ec9b0-13a5-49a8-b57b-b3f64e4316a7 (manufacturer Upsher-Smith Laboratories, LLC; abbreviated application ANDA075135), returned on 2026-10-30. The label text is dated 2025-07-14 (effective_time). Two repackager labels of Pacerone (Aphena, 2024-02-02; Bryant Ranch Prepack, 2025-11-05) and the labels of other amiodarone tablets and injections were listed and not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/cs-openfda-label-pacerone-us-b.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].indications_and_usage[0], 1, highlights, item 2",
          "applicability_note": "Highlights line: ventricular tachycardia.",
          "snapshot": {
            "id": "cardio:openfda-label-pacerone-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:30Z",
            "content_hash": "634bb6709ac6c7617c0112368b9bc30cf00ea37e42a72ee3e2302b2ee7725e3b",
            "source_effective_date": "2025-07-14",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-pacerone",
            "source_type": "regulator",
            "title": "openFDA drug label record for Pacerone (amiodarone hydrochloride tablets), Upsher-Smith label: indications, boxed warning and mechanism",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%224c4ec9b0-13a5-49a8-b57b-b3f64e4316a7%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 4c4ec9b0-13a5-49a8-b57b-b3f64e4316a7 (manufacturer Upsher-Smith Laboratories, LLC; abbreviated application ANDA075135), returned on 2026-10-30. The label text is dated 2025-07-14 (effective_time). Two repackager labels of Pacerone (Aphena, 2024-02-02; Bryant Ranch Prepack, 2025-11-05) and the labels of other amiodarone tablets and injections were listed and not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/cs-openfda-label-pacerone-us-b.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].boxed_warning[0], title",
          "applicability_note": "Title of the boxed warning.",
          "snapshot": {
            "id": "cardio:openfda-label-pacerone-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:30Z",
            "content_hash": "634bb6709ac6c7617c0112368b9bc30cf00ea37e42a72ee3e2302b2ee7725e3b",
            "source_effective_date": "2025-07-14",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-pacerone",
            "source_type": "regulator",
            "title": "openFDA drug label record for Pacerone (amiodarone hydrochloride tablets), Upsher-Smith label: indications, boxed warning and mechanism",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%224c4ec9b0-13a5-49a8-b57b-b3f64e4316a7%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 4c4ec9b0-13a5-49a8-b57b-b3f64e4316a7 (manufacturer Upsher-Smith Laboratories, LLC; abbreviated application ANDA075135), returned on 2026-10-30. The label text is dated 2025-07-14 (effective_time). Two repackager labels of Pacerone (Aphena, 2024-02-02; Bryant Ranch Prepack, 2025-11-05) and the labels of other amiodarone tablets and injections were listed and not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/cs-openfda-label-pacerone-us-b.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].boxed_warning[0], sentence 1",
          "applicability_note": "First sentence of the boxed warning.",
          "snapshot": {
            "id": "cardio:openfda-label-pacerone-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:30Z",
            "content_hash": "634bb6709ac6c7617c0112368b9bc30cf00ea37e42a72ee3e2302b2ee7725e3b",
            "source_effective_date": "2025-07-14",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-pacerone",
            "source_type": "regulator",
            "title": "openFDA drug label record for Pacerone (amiodarone hydrochloride tablets), Upsher-Smith label: indications, boxed warning and mechanism",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%224c4ec9b0-13a5-49a8-b57b-b3f64e4316a7%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 4c4ec9b0-13a5-49a8-b57b-b3f64e4316a7 (manufacturer Upsher-Smith Laboratories, LLC; abbreviated application ANDA075135), returned on 2026-10-30. The label text is dated 2025-07-14 (effective_time). Two repackager labels of Pacerone (Aphena, 2024-02-02; Bryant Ranch Prepack, 2025-11-05) and the labels of other amiodarone tablets and injections were listed and not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/cs-openfda-label-pacerone-us-b.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].boxed_warning[0], pulmonary",
          "applicability_note": "Pulmonary toxicity statement in the boxed warning.",
          "snapshot": {
            "id": "cardio:openfda-label-pacerone-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:30Z",
            "content_hash": "634bb6709ac6c7617c0112368b9bc30cf00ea37e42a72ee3e2302b2ee7725e3b",
            "source_effective_date": "2025-07-14",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-pacerone",
            "source_type": "regulator",
            "title": "openFDA drug label record for Pacerone (amiodarone hydrochloride tablets), Upsher-Smith label: indications, boxed warning and mechanism",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%224c4ec9b0-13a5-49a8-b57b-b3f64e4316a7%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 4c4ec9b0-13a5-49a8-b57b-b3f64e4316a7 (manufacturer Upsher-Smith Laboratories, LLC; abbreviated application ANDA075135), returned on 2026-10-30. The label text is dated 2025-07-14 (effective_time). Two repackager labels of Pacerone (Aphena, 2024-02-02; Bryant Ranch Prepack, 2025-11-05) and the labels of other amiodarone tablets and injections were listed and not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/cs-openfda-label-pacerone-us-b.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].boxed_warning[0], hepatic",
          "applicability_note": "Liver toxicity statement in the boxed warning (the label spells the word hepatoxicity).",
          "snapshot": {
            "id": "cardio:openfda-label-pacerone-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:30Z",
            "content_hash": "634bb6709ac6c7617c0112368b9bc30cf00ea37e42a72ee3e2302b2ee7725e3b",
            "source_effective_date": "2025-07-14",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-pacerone",
            "source_type": "regulator",
            "title": "openFDA drug label record for Pacerone (amiodarone hydrochloride tablets), Upsher-Smith label: indications, boxed warning and mechanism",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%224c4ec9b0-13a5-49a8-b57b-b3f64e4316a7%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 4c4ec9b0-13a5-49a8-b57b-b3f64e4316a7 (manufacturer Upsher-Smith Laboratories, LLC; abbreviated application ANDA075135), returned on 2026-10-30. The label text is dated 2025-07-14 (effective_time). Two repackager labels of Pacerone (Aphena, 2024-02-02; Bryant Ranch Prepack, 2025-11-05) and the labels of other amiodarone tablets and injections were listed and not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/cs-openfda-label-pacerone-us-b.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "supports",
          "locator": "results[0].boxed_warning[0], cardiac",
          "applicability_note": "Arrhythmia statement in the boxed warning.",
          "snapshot": {
            "id": "cardio:openfda-label-pacerone-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:30Z",
            "content_hash": "634bb6709ac6c7617c0112368b9bc30cf00ea37e42a72ee3e2302b2ee7725e3b",
            "source_effective_date": "2025-07-14",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-pacerone",
            "source_type": "regulator",
            "title": "openFDA drug label record for Pacerone (amiodarone hydrochloride tablets), Upsher-Smith label: indications, boxed warning and mechanism",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%224c4ec9b0-13a5-49a8-b57b-b3f64e4316a7%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 4c4ec9b0-13a5-49a8-b57b-b3f64e4316a7 (manufacturer Upsher-Smith Laboratories, LLC; abbreviated application ANDA075135), returned on 2026-10-30. The label text is dated 2025-07-14 (effective_time). Two repackager labels of Pacerone (Aphena, 2024-02-02; Bryant Ranch Prepack, 2025-11-05) and the labels of other amiodarone tablets and injections were listed and not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/cs-openfda-label-pacerone-us-b.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        },
        {
          "evidence_role": "context",
          "locator": "results[0].effective_time",
          "applicability_note": "Effective date of the label text read, 20250714.",
          "snapshot": {
            "id": "cardio:openfda-label-pacerone-2026-10-30",
            "retrieved_at": "2026-10-30T19:46:30Z",
            "content_hash": "634bb6709ac6c7617c0112368b9bc30cf00ea37e42a72ee3e2302b2ee7725e3b",
            "source_effective_date": "2025-07-14",
            "public_archive_url": null,
            "source_state": "current"
          },
          "source": {
            "id": "cardio:openfda-label-pacerone",
            "source_type": "regulator",
            "title": "openFDA drug label record for Pacerone (amiodarone hydrochloride tablets), Upsher-Smith label: indications, boxed warning and mechanism",
            "canonical_url": "https://api.fda.gov/drug/label.json?search=set_id:%224c4ec9b0-13a5-49a8-b57b-b3f64e4316a7%22&limit=1",
            "identifiers": [],
            "publication_date": null,
            "publisher": "U.S. Food and Drug Administration (openFDA)",
            "edition": "The openFDA drug label record for set id 4c4ec9b0-13a5-49a8-b57b-b3f64e4316a7 (manufacturer Upsher-Smith Laboratories, LLC; abbreviated application ANDA075135), returned on 2026-10-30. The label text is dated 2025-07-14 (effective_time). Two repackager labels of Pacerone (Aphena, 2024-02-02; Bryant Ranch Prepack, 2025-11-05) and the labels of other amiodarone tablets and injections were listed and not used.",
            "reuse_basis": "openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-10-30, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed at research/snapshots/cs-openfda-label-pacerone-us-b.json.",
            "public_text": "quote",
            "replaced_by": null,
            "retirement_note": null
          }
        }
      ],
      "review": {
        "content_digest": "d23c653a56fe14af3f58ae85714b7b692fca1248911ef21ce23639a6ecbac153",
        "current": [],
        "conflicting": [],
        "stale": [],
        "inactive": []
      },
      "api_path": "api/v1/claims/cardio--claim-fda-pacerone-label-indications.json"
    }
  ],
  "decisions": [],
  "milestones": [],
  "relationships": {
    "outgoing": [
      {
        "predicate": "evaluated_for",
        "label": "The US tablet label lists recurrent hemodynamically unstable ventricular tachycardia",
        "clinical_claim_not_fact": true,
        "family": "clinical",
        "other_entity_id": "cardio:ventricular-tachycardia",
        "other_entity_in_atlas": true,
        "claim_id": "cardio:claim-fda-pacerone-label-indications",
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "part_of",
        "label": "Filed under this front",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:front-medicines",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "subtype_of",
        "label": "The FDA established pharmacologic class of amiodarone in RxClass is Antiarrhythmic",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:antiarrhythmic-drugs",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:rxclass-703-2026-10-30",
          "locator": "rxclassDrugInfoList.rxclassDrugInfo[0].rxclassMinConceptItem.className"
        },
        "primary": true,
        "role": null,
        "valid_from": null,
        "valid_to": null
      }
    ],
    "incoming": [
      {
        "predicate": "related_to",
        "label": "Related to",
        "clinical_claim_not_fact": false,
        "family": "navigation",
        "other_entity_id": "cardio:dronedarone",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": null,
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01173809",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01173809-2014-08-21",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01229254",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01229254-2023-08-07",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01401647",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01401647-2017-04-17",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct01817439",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct01817439-2013-03-25",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct02132767",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct02132767-2019-03-15",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct02145546",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct02145546-2014-05-23",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct02715687",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct02715687-2016-03-22",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct03193749",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct03193749-2017-06-21",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct03715556",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct03715556-2018-10-23",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct03855826",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct03855826-2019-02-27",
          "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct04223739",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct04223739-2020-01-10",
          "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct04234906",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct04234906-2022-03-15",
          "locator": "protocolSection.armsInterventionsModule.interventions[2].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct04845607",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct04845607-2021-06-21",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct05287191",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct05287191-2024-04-25",
          "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct05543278",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct05543278-2026-06-30",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct06645249",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct06645249-2024-12-02",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct06680869",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct06680869-2025-12-19",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct06835491",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct06835491-2025-12-23",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct07273994",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct07273994-2025-12-10",
          "locator": "protocolSection.armsInterventionsModule.interventions[0].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "investigates",
        "label": "Investigated in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:ct-nct07887022",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ctgov-nct07887022-2026-10-21",
          "locator": "protocolSection.armsInterventionsModule.interventions[1].name"
        },
        "primary": false,
        "role": null,
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda018972",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda018972-2018-10-17",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda020377",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda020377-2009-03-13",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda021594",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda021594-2004-02-04",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      },
      {
        "predicate": "contains",
        "label": "Contained in",
        "clinical_claim_not_fact": false,
        "family": "sourced",
        "other_entity_id": "cardio:fdaprod-nda022325",
        "other_entity_in_atlas": true,
        "claim_id": null,
        "evidence": {
          "snapshot_id": "cardio:ofeed-nda022325-2025-02-21",
          "locator": "products[0].active_ingredients[0].name"
        },
        "primary": false,
        "role": "active",
        "valid_from": null,
        "valid_to": null
      }
    ]
  },
  "page_path": "drugs/amiodarone/",
  "context_path": "api/v1/context/cardio--amiodarone.md"
}
